One vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention

Affiliations

Comment

Wei Keith Tan. JAMA. 2019.

. 2019 Nov 5;322(17):1715.

doi: 10.1001/jama.2019.14223.

No abstract available

Comment in

1 vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention-Reply.
Watanabe H, Kimura T. Watanabe H, et al. JAMA. 2019 Nov 5;322(17):1715-1716. doi: 10.1001/jama.2019.14250. JAMA. 2019. PMID: 31688882 No abstract available.

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators. Watanabe H, et al. JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145. JAMA. 2019. PMID: 31237644 Free PMC article. Clinical Trial.